New York, December 15, 2023
PRISM MediaWire – Weekly Press Resume
Dec. 11 to Dec. 15, 2023
UAT Group Receives Financing for Iron Removal System
SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies
MyMD Tackles Rheumatoid Arthritis with Launch of Phase 2 Trial in Early 2024
Hand-Spun Success: Why Did Shake Shack’s Shares Jump Today?
OpenLocker Holdings Provides Year-End Letter to Shareholders
INTK Announces Senior Management Changes; Substantial Share Retirement And Cancels Reverse Split
Metatron Pioneers AI-driven Content Discovery and issues Reverse Split Moratorium
PRISM MarketView Launches Emerging AdTech and Media Index
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE
Clubhouse Media Group, Inc. Announces Model Talia Mint Joins HoneyDrip.com
GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Agreement to Reload Lovelace Medical Center with New Cobalt Sources and Software Upgrade
BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan
FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%
PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation
Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024
Center for Medicare Services Established National Pricing of AmnioWrap2 (TM) in All MAC Regions
PRISM AdTech & Media Company Spotlight: Creative Realities (CREX) Illuminates the Future of Experiential Design
SinglePoint Announces Pricing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
SinglePoint, Inc.–The Inaugural US Company to List on Cboe BZX Exchange
“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial
PRISM MediaWire
Phone: (646) 863-7997
Email: twolff@prismmediawire.com
Website: https://prismmediawire.com/
https://form.jotform.com/233255837419867 https://form.jotform.com/233256511839863
